Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 6 | 2015 | 61 | 1.330 |
Why?
|
| Macrophage Colony-Stimulating Factor | 5 | 2020 | 10 | 0.950 |
Why?
|
| Arteriosclerosis | 6 | 2004 | 42 | 0.910 |
Why?
|
| Osteoclasts | 2 | 2015 | 28 | 0.670 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 5 | 0.500 |
Why?
|
| Giant Cells | 1 | 2015 | 15 | 0.480 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 25 | 0.470 |
Why?
|
| Lipoproteins, LDL | 3 | 2011 | 66 | 0.460 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2020 | 142 | 0.450 |
Why?
|
| Macrophages | 4 | 2020 | 515 | 0.440 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 95 | 0.350 |
Why?
|
| Estradiol | 1 | 2011 | 269 | 0.310 |
Why?
|
| Albuminuria | 3 | 2020 | 78 | 0.300 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 164 | 0.300 |
Why?
|
| Arteries | 3 | 2004 | 81 | 0.300 |
Why?
|
| Coronary Vessels | 3 | 2005 | 92 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1066 | 0.250 |
Why?
|
| Brachytherapy | 2 | 2004 | 11 | 0.240 |
Why?
|
| Lipoproteins | 1 | 2005 | 68 | 0.220 |
Why?
|
| Endocrine System | 1 | 2004 | 12 | 0.220 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2004 | 16 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 164 | 0.210 |
Why?
|
| Coronary Restenosis | 2 | 2004 | 27 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 221 | 0.200 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 138 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 458 | 0.190 |
Why?
|
| Bone and Bones | 1 | 2003 | 115 | 0.190 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 4 | 0.190 |
Why?
|
| Mice | 8 | 2020 | 6490 | 0.170 |
Why?
|
| Immunoblotting | 2 | 2016 | 181 | 0.170 |
Why?
|
| Animals | 13 | 2020 | 16695 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2002 | 400 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2020 | 1010 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 92 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1554 | 0.160 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 74 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2020 | 164 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2020 | 324 | 0.150 |
Why?
|
| Models, Biological | 1 | 2002 | 711 | 0.150 |
Why?
|
| Inflammation | 1 | 2003 | 729 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1804 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 456 | 0.130 |
Why?
|
| Male | 10 | 2020 | 22779 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2011 | 1617 | 0.130 |
Why?
|
| Rabbits | 1 | 2016 | 292 | 0.120 |
Why?
|
| Monocytes | 2 | 2011 | 275 | 0.120 |
Why?
|
| Humans | 12 | 2020 | 42163 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1420 | 0.110 |
Why?
|
| Female | 8 | 2020 | 24018 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 239 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2014 | 99 | 0.100 |
Why?
|
| Middle Aged | 5 | 2020 | 11819 | 0.100 |
Why?
|
| Apoptosis | 1 | 2020 | 1541 | 0.100 |
Why?
|
| Aged | 4 | 2020 | 7982 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.090 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 51 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 744 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1737 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 63 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2011 | 57 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 117 | 0.080 |
Why?
|
| Apolipoproteins E | 3 | 2011 | 137 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2011 | 71 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2803 | 0.070 |
Why?
|
| Follistatin | 1 | 2008 | 28 | 0.070 |
Why?
|
| Muscle Development | 1 | 2008 | 51 | 0.070 |
Why?
|
| Rats | 1 | 2016 | 3701 | 0.070 |
Why?
|
| beta Catenin | 1 | 2008 | 75 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 107 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 144 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 214 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1848 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 263 | 0.060 |
Why?
|
| Tunica Intima | 2 | 2004 | 21 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 12 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2005 | 46 | 0.060 |
Why?
|
| Methods | 1 | 2005 | 14 | 0.060 |
Why?
|
| Anion Exchange Resins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Preservation, Biological | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lipoproteins, VLDL | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 52 | 0.060 |
Why?
|
| Swine | 2 | 2004 | 205 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 990 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2005 | 47 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 48 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 236 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2005 | 61 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 23 | 0.060 |
Why?
|
| Echocardiography | 1 | 2005 | 167 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2008 | 633 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2004 | 6 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 70 | 0.050 |
Why?
|
| Catheterization | 1 | 2004 | 22 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2004 | 47 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 146 | 0.050 |
Why?
|
| Bone Development | 1 | 2003 | 28 | 0.050 |
Why?
|
| Aorta | 2 | 2020 | 197 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2004 | 884 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 78 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 928 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 230 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 79 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1131 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 149 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2002 | 59 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 4 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Catalysis | 1 | 2002 | 191 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2002 | 19 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 246 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 77 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 462 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 314 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2002 | 411 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 454 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2020 | 52 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 72 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2020 | 40 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 379 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 122 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 541 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 102 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 318 | 0.040 |
Why?
|
| Urinalysis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2020 | 2111 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 102 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 438 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1265 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 512 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 13458 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1586 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 845 | 0.030 |
Why?
|
| Child | 1 | 2005 | 3381 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1054 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 144 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3077 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 3942 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 19 | 0.020 |
Why?
|
| Selenomethionine | 1 | 2011 | 13 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 31 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 76 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 105 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 79 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 233 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 152 | 0.020 |
Why?
|
| United States | 1 | 2020 | 5072 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 20 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 38 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 295 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 383 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 382 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 15 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2004 | 46 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 43 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 51 | 0.010 |
Why?
|
| Tunica Media | 1 | 2004 | 14 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2004 | 8 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2004 | 19 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 23 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 7 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2004 | 35 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 64 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 28 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 106 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 169 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 72 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 80 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 168 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 95 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 140 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 120 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 4936 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 206 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 177 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 256 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 261 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 774 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 548 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 860 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 532 | 0.010 |
Why?
|